Adagio medical provides clinical and business updates

Laguna hills, calif.--(business wire)--adagio medical holdings, inc. (nasdaq: adgm; the “company”), a leading innovator in catheter ablation technologies, provided updates today on the progress in its streamlined focus on leadership in ventricular tachycardia (“vt”) solutions. recent business highlights: the company will participate in the scientific program of the 2025 european heart rhythm association (the “association”) annual meeting to be held from march 30 through april 1 in vienna, austr.
ADGM Ratings Summary
ADGM Quant Ranking